Anavar PCT: Do You Need It, What to Take and When to Start

Anavar PCT is the post-cycle therapy men run after oxandrolone to restart natural testosterone production, and it is the most argued-about part of the cycle. One camp says oxandrolone is too mild to suppress anything and PCT is a waste of money. The other says every anabolic steroid shuts the axis down and PCT is mandatory. The blood work settles it, and it does not settle it in the first camp's favour: oxandrolone suppresses LH, FSH and testosterone at every dose that produces results, and whether a given user needs PCT is a question the week-four hormone panel answers, not the forum.

This guide covers what the suppression actually looks like in numbers, when Anavar PCT is needed and when it is not, the protocols — tamoxifen, clomiphene, enclomiphene — with doses and durations, when to start depending on what else was in the cycle, what happens to the user who skips it, the situation for women, and how to confirm recovery has happened rather than assuming it.

Yes, and the evidence is not anecdotal. The clinical trials that established oxandrolone as a treatment for wasting and for older men used 20 mg a day, and they recorded reductions in LH, FSH and total testosterone within weeks — at a dose half of what recreational users run. At 40–50 mg the community blood work is consistent: LH and FSH fall first, usually to the bottom of the reference range by week three; total testosterone follows, down 30–50% by week four; and by week six a minority of users show near-complete suppression, with testosterone under 200 ng/dL.

The confusion comes from the symptoms rather than the numbers. Oxandrolone is itself an androgen, so a user in a suppressed state still has strength, pumps and a hard look — the oral is covering for the testosterone that is missing. What it does not cover well is libido and mood, which is why the second half of an Anavar-only cycle so often feels flat. The Anavar only cycle guide covers that version in detail; the point here is that suppression is real, measurable and dose-dependent, and "does Anavar lower testosterone" has a one-word answer.

The decision splits cleanly by situation. A man who ran oxandrolone alone at 40 mg or more for five weeks or longer needs PCT: the suppression is significant and natural recovery without help takes six to twelve weeks in most users, during which the gains erode. A man who ran it on a testosterone base needs PCT for the testosterone, not for the oxandrolone — the base is what shut the axis down — and the timing is governed by the ester, not the oral. A man on TRT does not need PCT at all: his axis is suppressed by design and stays that way, and stopping oxandrolone simply removes the oral while the testosterone continues, which is why the Anavar TRT clinic guide never mentions it.

The grey zone is the short, low-dose solo cycle — 20–30 mg for four weeks — where some users recover naturally within three to four weeks. Even there, the sensible approach is blood work at the end of the cycle: if LH and testosterone are already climbing, PCT can be skipped; if they are not, it starts. Women running 5–10 mg do not run SERM-based PCT, for reasons covered below.

PCT is decided before the cycle, bought before the cycle, and started on the date the plan says — not when the user notices something is wrong.

Three compounds do the job of post cycle therapy for Anavar, and all three are selective estrogen receptor modulators that block estrogen's negative feedback at the hypothalamus, so that LH and FSH rise and the testes restart. They differ in dose, side effects and how well tolerated they are.

For a standalone oxandrolone cycle, tamoxifen alone at 20 mg for four weeks is the community standard and the one most blood work supports. Clomiphene is the choice for users who ran higher doses or longer, or whose end-of-cycle panel shows deeper suppression. Enclomiphene is increasingly preferred by those who can get it, because it delivers clomiphene's effect without the isomer responsible for most of its side effects. HCG during PCT is unnecessary after oxandrolone alone — it belongs to longer injectable cycles where testicular atrophy has occurred. Over-the-counter "PCT" products built on D-aspartic acid, tribulus or arimistane do not restart a suppressed axis and should not be relied on for that.

Timing depends on what needs to clear. Oxandrolone's half-life is nine to ten hours, so it is gone from the system in about two days; PCT after an oral-only cycle starts one to two days after the last tablet. Starting earlier is pointless because the oxandrolone is still suppressing the axis; starting later leaves the user in a low state for no reason.

If testosterone was in the cycle, the oral becomes irrelevant to timing and the ester governs. After testosterone propionate, PCT starts three to five days after the last injection; after enanthate or cypionate, two weeks; after a long blend such as Sustanon, two and a half to three weeks. The Anavar and test cycle guide sets out the full schedule for a combined run, and the Anavar half life guide explains why the oral clears so fast.

The user who skips PCT after a solo cycle falls into one of two groups. Roughly a quarter to a third — usually younger, with a short cycle and a strong baseline — see LH and testosterone climb back within three to four weeks on their own and lose little. The rest spend six to twelve weeks with testosterone well below baseline, and during that window the pattern is consistent: libido gone, mood flat, sleep poor, training motivation low, and the lean tissue gained on cycle steadily lost because there is no androgen to hold it. Estrogen, no longer balanced by testosterone, can drift upward and produce soft tissue in the chest even though oxandrolone itself never aromatised.

The financial arithmetic is unforgiving. Tamoxifen for four weeks costs $20–40. A six-week oxandrolone cycle, with base, liver support and blood work, costs $500–1,100. Skipping the cheapest item to protect the most expensive one is the mistake that appears most often in the Anavar Reddit reviews — usually in the post written at week ten.

Women do not run SERM-based Anavar PCT, and the reason is physiological rather than a matter of caution. Tamoxifen and clomiphene work by stimulating LH and FSH to restart testicular testosterone production; in women the relevant axis governs the menstrual cycle, and SERMs disrupt it rather than restore it. A woman finishing a 5–10 mg cycle stops the tablets, allows four to eight weeks for her natural cycle to normalise if it was affected, and takes at least as long off as she was on. Blood work — estradiol, testosterone, SHBG — confirms recovery if there is any doubt.

The exceptions are narrow. A woman who ran unusually high doses or long cycles and whose cycle has not returned after eight weeks needs a physician, not a PCT protocol. The Anavar side effects in women guide covers the signs that call for stopping early.

Recovery is confirmed by blood work, not by feeling better. Four to six weeks after PCT ends, a hormone panel should show total testosterone back within 10–15% of the pre-cycle baseline, LH and FSH in the normal range, and estradiol normal. If testosterone is back but LH is still low, the axis has not fully recovered and a second short course of PCT is reasonable. If neither has moved after a full protocol, that is the point to involve a physician rather than extend the SERMs indefinitely. The Anavar results week by week guide lists the panels at each checkpoint, and the Anavar cycle guide shows where PCT sits in the full timeline.

The baseline is the number everything is measured against, which is the strongest argument for the pre-cycle panel most first-time users skip. Without it, "recovered" is a guess.

This article is for educational and harm-reduction purposes only and is not medical advice. Oxandrolone, tamoxifen and clomiphene are prescription-only or controlled substances in most countries; anyone considering them should consult a licensed physician.

Anavar.org is an independent educational resource. We are not affiliated with any pharmaceutical manufacturer or healthcare provider. This content is for informational purposes only and does not constitute medical advice.